@文章{信息:doi/10.2196/15641，作者=“Piau, Antoine和Steinmeyer, Zara和Charlon, Yoann和Courbet, Laetitia和Rialle, Vincent和Lepage, Benoit和Campo, Eric和Nourhashemi, Fati”，标题=“智能鞋垫监测虚弱老年人的行走速度:“生活实验室和12周试点研究完成的两个评价阶段结果”，期刊=“JMIR Mhealth Uhealth”，年=“2021”，月=“7月”，日=“5”，卷=“9”，数=“7”，页=“e15641”，关键词=“体弱老年人;步行速度;门诊监测;活动跟踪;背景:世界卫生组织最近的报告提出，可穿戴设备可以收集活动和步行速度的信息，作为创新的健康指标。然而，主流消费级跟踪设备和智能手机应用程序往往不准确，需要长期的可接受性评估。目的:我们的目的是评估虚弱的老年人对内置鞋垫的用户接受度。该设备监测参与者的行走速度，并在步长校准后区分主动行走和拖曳。方法:设计了一个多阶段评估:9名老年人在生活实验室进行了一天的评估，3名老年人在家里进行了一个月的评估，一项前瞻性随机试验包括35名老年人在家里进行了3个月的评估。 A qualitative research design using face-to-face and phone semistructured interviews was performed. Our hypothesis was that this shoe insole was acceptable in monitoring long-term outdoor and indoor walking. The primary outcome was participants' acceptability, measured by a qualitative questionnaire and average time of insole wearing per day. The secondary outcome described physical frailty evolution in both groups. Results: Living lab results confirmed the importance of a multiphase design study with participant involvement. Participants proposed insole modifications. Overall acceptability had mixed results: low scores for reliability (2.1 out of 6) and high scores for usability (4.3 out of 6) outcomes. The calibration phase raised no particular concern. During the field test, a majority of participants (mean age 79 years) were very (10/16) or quite satisfied (3/16) with the insole's comfort at the end of the follow-up. Participant insole acceptability evolved as follows: 63{\%} (12/19) at 1 month, 50{\%} (9/18) at 2 months, and 75{\%} (12/16) at 3 months. A total of 9 participants in the intervention group discontinued the intervention because of technical issues. All participants equipped for more than a week reported wearing the insole every day at 1 month, 83{\%} (15/18) at 2 months, and 94{\%} (15/16) at 3 months for 5.8, 6.3, and 5.1 hours per day, respectively. Insole data confirmed that participants effectively wore the insole without significant decline during follow-up for an average of 13.5 days per 4 months and 5.6 hours per day. For secondary end points, the change in frailty parameters or quality of life did not differ for those randomly assigned to the intervention group compared to usual care. Conclusions: Our study reports acceptability data on an instrumented insole in indoor and outdoor walking with remote monitoring in frail older adults under real-life conditions. To date, there is limited data in this population set. This thin instrumentation, including a flexible battery, was a technical challenge and seems to provide an acceptable solution over time that is valued by participants. However, users still raised certain acceptability issues. Given the growing interest in wearable health care devices, these results will be useful for future developments. Trial Registration: ClinicalTrials.gov NCT02316600; https://clinicaltrials.gov/ct2/show/NCT02316600 ", issn="2291-5222", doi="10.2196/15641", url="https://mhealth.www.mybigtv.com/2021/7/e15641", url="https://doi.org/10.2196/15641" }